Publications
- Pathological cut-offs of global and regional brain volume loss in multiple sclerosis2019 | First Faculty of Medicine
- Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a2015 | First Faculty of Medicine
- Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome2013 | First Faculty of Medicine
- Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study2012 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Current and future therapeutic options for the treatment of the generalized form of myasthenia gravis2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
Loading network view...